Lv1
100 积分 2024-06-17 加入
Application of new approach methodologies for nonclinical safety assessment of drug candidates
5小时前
待确认
Olezarsen: First Approval
1个月前
已完结
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
3个月前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
3个月前
已完结
Ublituximab: First Approval
4个月前
已完结
CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies
4个月前
已完结
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
6个月前
已完结
Evinacumab: First Approval
6个月前
已完结
Randomized Phase I Trials - One Size Fits All?
8个月前
已完结
Apolipoprotein C-III Inhibition - Killing Two Birds with One Stone?
8个月前
已完结
皖公网安备34019202002308
